PNMA6A and infection: All mAbs tested, including 580 and 663, were able to block hepatocyte invasion, with MA1 and MA8 demonstrating a reduction in infection of 35% and 52%, respectively, while 580, 663, and MA6 all demonstrated more than 85% ISI activity (Fig. 4 B).